Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection.

Hepatology (Baltimore, Md.) - 1 Dec 2007

Hraber Peter, Kuiken Carla, Yusim Karina

Abstract excerpt

UNLABELLED: Outcomes of infection with hepatitis C virus (HCV) vary widely, from asymptomatic clearance to chronic infection, leading to complications that include fibrosis, cirrhosis, hepatocellular carcinoma, and liver failure. Previous studies have reported statistical associations between human leukocyte antigen (HLA) heterozygosity and favorable outcomes of infection with either hepatitis B virus (HBV) or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Diabetes and associated disorders
Share to Haplotypes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Hepatitis C virus research

Share to Heterozygote

Share to HLA Antigens

Share to Liver Diseases and Immunity

Source

Identifiers

PMID: 17935228
DOI: 10.1002/hep.21889

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection.PMID 17935228Read ↗

HLA Zygosity Increases Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma.Semantic proximity Read ↗

HLA Genetic Diversity and Chronic Hepatitis B Virus Infection: Effect of Heterozygosity Advantage.Semantic proximity Read ↗

Effect of human leukocyte antigen heterozygosity on infectious disease outcome: the need for allele-specific measures.Semantic proximity Read ↗

Heterozygote advantage for HLA class-II type in hepatitis B virus infectionSemantic proximity Read ↗

HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation.Semantic proximity Read ↗

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.Semantic proximity Read ↗

HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C.Semantic proximity Read ↗

Human leukocyte antigen–associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution†Semantic proximity Read ↗

Association between human leucocyte antigen-DO polymorphisms and interferon/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study.Semantic proximity Read ↗

Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.Semantic proximity Read ↗

Hepatitis B infection outcome is associated with novel human leukocyte antigen variants in Ghanaian cohort.Semantic proximity Read ↗

Host genetic determinants in hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.